insights_auto
Bakit tumaas ang ALNOV 2.44%?
Tingnan ang Higit pang Detalyechevron_right
ALNOV:EPA
Novacyt SA
€0.46
arrow_upward
+2.44%(+0.011) 1D
Okt 5, 5:35:12 PM GMT+2 · EUR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa ALNOV...
Buksan
€0.46
Mataas
€0.47
Mababa
€0.46
Mkt. cap
33.53M
Avg. na dami
260.56K
Dami
243.90K
Mataas nang 52-wk
€1.04
Mababa nang 52-wk
€0.29
EPS
-€0.39
Mga natitirang share
72.59M
Bilang ng mga empleyado
216
Buksan
€0.46
Mataas
€0.47
Mababa
€0.46
Mkt. cap
33.53M
Avg. na dami
260.56K
Dami
243.90K
Mataas nang 52-wk
€1.04
Mababa nang 52-wk
€0.29
EPS
-€0.39
Mga natitirang share
72.59M
Bilang ng mga empleyado
216
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Reuters
·
1 oras ang nakalipas
S&P 500 up, Nasdaq at record high as megacap tech stocks rise
Goldman Sachs
·
1 linggo ang nakalipas
Can AI Investment Drive S&P 500 Earnings Even Higher?
MarketWatch
·
3 araw ang nakalipas
The stock market is anything but normal right now — and these charts show it
Bloomberg.com
·
5 araw ang nakalipas
Stocks and Bonds Pause Ahead of US Data, Micron: Markets Wrap
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Tungkol sa Novacyt SA